# E2E Test: BuildDischargePacket — Sarah Kim
Date: 2026-05-02

## Results

1. medicationReconciliation — PASS — Rivaroxaban (Xarelto) 20 MG correctly classified as **New** (started 2026-04-07, post-admission); Amlodipine 5 MG and Sertraline 50 MG correctly classified as **Continued** (pre-admission, unchanged dosage); Stopped and Changed lists both empty as expected; no spurious interaction warnings or allergy conflicts returned.

2. readmissionRisk — PASS — LACE = 4 (Low). Breakdown: L=3 (4-day stay), A=0 (planned admission, no ER admit source), C=0 (DVT and hip fracture carry no Charlson weight), E=1 (1 prior ER visit). Correct low-risk recommendation returned: "Routine follow-up. Schedule PCP visit within 30 days."

3. dischargeInstructions — PASS — Clinician packet contained the full visit narrative (45-year-old female, April 6–10, 4-day stay, correct diagnoses and procedures). Patient packet rendered with proper you/your tone; abbreviations expanded correctly (e.g. "DVT" → "deep vein thrombosis", "INR" → "Blood Clotting Level (INR)", "CBC" → "Complete Blood Count (CBC)"); Rivaroxaban correctly badged **(NEW)**; DVT-specific diet guidance (anticoagulation note, no vitamin K restriction for rivaroxaban/apixaban) and condition-specific warning signs served correctly.

4. followUpPlan — PASS — Four items generated across two condition rules: DVT rule produced a 1-week PCP/Vascular Surgery visit (anticoagulation management) and a 3–5-day lab order (INR + CBC); hip-fracture rule produced a 1–2-week Orthopedics visit and a 4–6-week imaging follow-up (X-ray for fracture alignment). Patient packet correctly omitted specialty labels and rendered lab tests by name. Deduplication and CarePlan-coverage filter ran without error.

5. costSavings — PASS — Brand-to-generic substitution fired correctly on Rivaroxaban (Xarelto) 20 MG, returning a suggested generic equivalent with an estimated monthly savings of **$180**. Local lookup and RxNav fallback paths both functional; allergy filter ran without issue.

6. Fault tolerance — PASS — All five sub-tools (`reconcileMedications`, `generateDischargeInstructions`, `assessReadmissionRisk`, `planFollowUp`, `auditMedCosts`) completed without throwing; no `{ error: "…" }` envelope appeared in any section; `runSafe` wrappers were not invoked defensively. Full structured JSON returned with `generatedAt` timestamp and disclaimer.

## Notes

- Abbreviation expansion verified end-to-end: "DVT" → "deep vein thrombosis", "ORIF" retained as part of its procedure display name, "INR" and "CBC" both expanded in the patient-facing follow-up appointment list — all consistent with `medical-abbreviations.ts`.
- Patient packet correctly excluded LACE score, cost savings details, and medication reconciliation change types from the patient-facing section, per rendering rules.
- `askCareTeamReminder` rendered as a callout at the bottom of the patient packet as expected.
